The Talaska Law Firm is now investigating cases where children were born with birth defects due to the drug Zofran (odansetron).
Zofran is prescribed by doctors to women during pregnancy as a treatment for nausea and vomiting. Recently, medical studies have found that the use of Zofran during pregnancy can cause children to be born with birth defects.
When first approved by the FDA, Zofran was marketed to cancer patients who were experiencing severe nausea and vomiting due to chemotherapy. As time passed, Zofran’s manufacturer, GlaxoSmithKline, discovered that Zofran could also be effective in pregnant women. Although the FDA never approved Zofran for use in pregnant women to help combat nausea, GlaxoSmithKline continued to promote this “off-label” usage of Zofran.
Due to this off-label marketing, GlaxoSmithKline was brought up on federal fraud and illegal promotion charges. As a part of their criminal settlement, Zofran’s manufacturer plead guilty in 2012 and was forced to pay $3 Billion as a part of their settlement of these federal charges. Now that the medical literature shows the link between Zofran and certain birth defects, families have begun filing civil suits against GlaxoSmithKline for birth defects.
One of the first lawsuits filed against Zofran’s manufacturer was in February, 2015. As a part of the case, the Plaintiff alleged that had the true risks to the baby been told to her, she would have never agreed to take Zofran during her pregnancy. Some of the birth defects suffered due to Zofran usage include heart defects, such as septal defects, cleft lip or palate, club foot, and skull deformities.
If you think that your baby suffers from birth defects due to Zofran usage during pregnancy, please contact the Talaska Law Firm today at 713-869-1240 for your case evaluation. The law limits the amount of time you have to protect your rights, so contact us today.